Kyber Data Science Launches Next-Gen Health Care Data Platform for Institutional Investors

Rhea-AI Summary

Kyber Data Science, a subsidiary of Cowen (COWN), has launched a new user interface aimed at simplifying complex health care data for institutional investors. This next-generation tool allows quick access to extensive health care data sets, covering 300 million deidentified U.S. patients over seven years. Investors can now track critical health care treatment utilization, patient expansion rates, compliance, and payer insights, enabling better investment decisions in previously opaque markets.

Positive

• Launch of a next-generation user interface to simplify health care data analysis for investors.
• Access to a unique dataset covering 300 million deidentified U.S. patients.
• Ability to track utilization and market trends in complex health care areas.

Negative

• None.

New User Interface Enables Investors to Quickly See What Matters for Complex Health Care Products and Markets

NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) -- Institutional investors can now readily access the most diverse and granular source of real-world health care data available, enabling faster and more profitable decisions. Kyber Data Science (“Kyber”), a subsidiary of Cowen Inc. (NASDAQ: COWN) (“Cowen”), today unveiled a next-generation user experience to disentangle and simplify complex health care data and provide visibility into the specific market influences that drive performance.

Kyber Data Science is the first in its industry to enrich real-world health care data exclusively for the investment community. Its new dashboard allows investors to track utilization of health care treatments, even in pharmaceutical and biopharmaceuticals markets that have long been “information voids,” such as injectables and infusions, diagnostics, procedures and medical devices.

“For some time, Kyber has offered investors a unique dataset covering 300 million deidentified U.S. patients, with over seven years of longitudinal history,” said Jeff Forringer, CEO of Kyber Data Science. “Our new user interface makes this data even easier to analyze and generate actionable insights relevant to investment decisions.”

What Makes Kyber’s Data Unique?

Built by a team of health care data science experts within the Cowen ecosystem, Kyber Data Science’s offerings represent the next-generation evolution of investors’ existing health care data subscriptions.

Kyber’s new user interface tracks the most important signals to watch for across most health care procedures, prescriptions and services. Additionally, the Kyber team provides unique insights into areas where most investors today have limited or no visibility, such as:

1. Prescription and medically-administered treatment utilization, to help forecast revenue and market share trends
2. True new-to-brand patients, to better understand new patient expansion rates
3. Patient compliance and persistence, to quantify patient loyalty and market value
4. Payer-related insights, to track patient access and payer coverage for drugs of interest

To schedule a demonstration, contact Kyber@Cowen.com.

About Kyber Data Science
Kyber Data Science, a Cowen company, is an advanced health care data company that offers analytical tools to help health care investors make better portfolio decisions. It delivers enriched, real-world healthcare insights to help investors understand U.S. market forces, as they’re unfolding, across complex points of care and payment. Learn more at Kyber.ai.

About Cowen Inc.

Cowen Inc. (“Cowen” or the “Company”) is a diversified financial services firm offering investment banking services, equity and credit research, sales and trading, prime brokerage, global clearing, commission management services and actively managed alternative investment products. Cowen focuses on delivering value-added capabilities to our clients in order to help them outperform. Founded in 1918, the Company is headquartered in New York and has offices worldwide. Learn more at Cowen.com.

Media Contacts:

Gagnier Communications
Dan Gagnier / Jeffrey Mathews
646-569-5897
dg@gagnierfc.com

FAQ

What is the purpose of Kyber Data Science's new user interface?

The new user interface helps institutional investors analyze complex health care data quickly and efficiently.

How does Kyber Data Science support investment decisions?

Kyber provides insights into health care treatment utilization, patient trends, and payer coverage, facilitating informed investment choices.

What data does Kyber Data Science offer?

Kyber offers data covering 300 million deidentified U.S. patients with over seven years of longitudinal history.

What unique insights does Kyber provide investors?

Kyber provides insights on prescription utilization, patient expansion rates, compliance, and payer-related access data.

How can investors see Kyber's new dashboard in action?

Investors can schedule a demonstration of the new dashboard by contacting Kyber via their provided email.